首页 正文

Selenized Probiotic L. brevis 23017 Alleviates Colitis by Modulating the Nrf2-GPX4 Axis to Inhibit Ferroptosis

{{output}}
Ulcerative colitis (UC) constitutes a principal subtype of inflammatory bowel disease (IBD) and exhibits escalating global incidence. This study elucidates the therapeutic efficacy and mechanistic basis of novel selenized probiotic, Lactobacillus brevis 23017 ... ...